TherapeuticsMD Ownership | Who Owns TherapeuticsMD?


OverviewForecastRevenueFinancialsChart

TherapeuticsMD Ownership Summary


TherapeuticsMD is owned by 6.74% institutional investors, 7.45% insiders, and 85.81% retail investors. Rubric capital management lp is the largest institutional shareholder, holding 10.30% of TXMD shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.16% of its assets in TherapeuticsMD shares.

TXMD Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockTherapeuticsMD6.74%7.45%85.81%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustrySpecialty & Generic Drug Manufacturers Stocks20.67%13.90%65.43%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Rubric capital management lp1.19M10.30%$2.41M
Clearline capital lp635.22K5.49%$1.28M
Vanguard group397.06K3.43%$647.20K
Tejara capital345.85K2.99%$698.62K
Adar1 capital management209.21K1.81%$224.90K
Renaissance146.20K1.26%$295.32K
Morgan stanley129.22K1.12%$261.02K
Blackrock125.15K1.09%$201.50K
Blackrock funding, inc. /de115.14K1.00%$232.59K
Geode capital management109.82K0.95%$221.88K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Tejara capital345.85K0.23%$698.62K
Clearline capital lp635.22K0.07%$1.28M
Rubric capital management lp1.19M0.03%$2.41M
Adar1 capital management209.21K0.02%$224.90K
Two sigma securities11.97K0.00%$12.87K
Xtx topco27.49K0.00%$55.52K
Bridgeway capital management17.00K0.00%$34.34K
Renaissance146.20K0.00%$295.32K
J. goldman & co lp13.56K0.00%$14.58K
Tower research capital llc (trc)1.51K0.00%$3.05K

Top Buyers

HolderShares% AssetsChange
Vanguard fiduciary trust63.83K-63.83K
Renaissance146.20K0.00%49.70K
Citadel advisors68.31K-40.07K
Xtx topco27.49K0.00%27.49K
Vanguard group397.06K-20.23K

Top Sellers

HolderShares% AssetsChange
Clear harbor asset management---25.81K
Prosperity consulting group---24.50K
Ameriprise financial---22.47K
Susquehanna group, llp21.22K--13.94K
Gabelli funds---12.00K

New Positions

HolderShares% AssetsChangeValue
Vanguard fiduciary trust63.83K-63.83K$128.94K
Xtx topco27.49K0.00%27.49K$55.52K
Dimensional fund advisors lp10.71K-10.71K$21.63K
Vanguard global advisers4.94K-4.94K$9.97K
Wealth watch advisors22.00-22.00$24.00

Sold Out

HolderChange
Sterling capital management-1.00
Strategic advocates-1.00
Citigroup-1.00
Aspire private capital-1.00
Guardian wealth management-2.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202619-56.82%780,118-76.95%60.79%10-16.67%2-71.43%
Dec 31, 202531-27.91%2,422,829-26.67%202.57%8-2-80.00%
Sep 30, 202539-4.88%3,303,7511.48%283.61%6-45.45%1025.00%
Jun 30, 202540-2.44%3,254,871-2.65%283.36%10-9.09%912.50%
Mar 31, 2025402.56%3,343,569-5.25%283.09%11-860.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF249.66K2.16%-
Vanguard Total Stock Mkt Idx Inv244.32K2.11%-
Vanguard Institutional Extnd Mkt Idx Tr109.38K0.94%-
Fidelity Extended Market Index65.42K0.57%-1.80K
Extended Equity Market Fund E18.69K0.16%-
Extended Equity Market Fund B18.69K0.16%-
Blackrock Extended Mkt Fund CF18.69K0.16%-
Bridgeway Ultra-Small Company Market17.00K0.15%-
BlackRock Extended Equity Market K16.29K0.14%-7.00
Extended Equity Market Fund K15.91K0.14%-117.00

Recent Insider Transactions


DateNameRoleActivityValue
Dec 23, 2025Thompson Tommy G-Buy$14.03K
Apr 14, 2025Thompson Tommy G-Buy$325.59
Apr 14, 2025Walker Marlan D Chief Executive OfficerBuy$489.27
Apr 09, 2025Walker Marlan D Chief Executive OfficerBuy$993.66
Apr 10, 2025Walker Marlan D Chief Executive OfficerBuy$1.00K

Insider Transactions Trends


DateBuySell
2025 Q4--
2025 Q24-
2025 Q1--
2024 Q32-
2023 Q4-2

TXMD Ownership FAQ


Who Owns TherapeuticsMD?

TherapeuticsMD shareholders are primarily institutional investors at 6.74%, followed by 7.45% insiders and 85.81% retail investors. The average institutional ownership in TherapeuticsMD's industry, Specialty & Generic Drug Manufacturers Stocks, is 20.67%, which TherapeuticsMD falls below.

Who owns the most shares of TherapeuticsMD?

TherapeuticsMD’s largest shareholders are Rubric capital management lp (1.19M shares, 10.30%), Clearline capital lp (635.22K shares, 5.49%), and Vanguard group (397.06K shares, 3.43%). Together, they hold 19.23% of TherapeuticsMD’s total shares outstanding.

Does Blackrock own TherapeuticsMD?

Yes, BlackRock owns 1.09% of TherapeuticsMD, totaling 125.15K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 201.5K$. In the last quarter, BlackRock decreased its holdings by -10.627K shares, a -7.83% change.

Who is TherapeuticsMD’s biggest shareholder by percentage of total assets invested?

Tejara capital is TherapeuticsMD’s biggest shareholder by percentage of total assets invested, with 0.23% of its assets in 345.85K TherapeuticsMD shares, valued at 698.62K$.

Who is the top mutual fund holder of TherapeuticsMD shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of TherapeuticsMD shares, with 2.16% of its total shares outstanding invested in 249.66K TherapeuticsMD shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools